Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

UPDATE 1-Oil stocks help FTSE 100 outperform amid trade tensions

Published 19/06/2018, 02:27 am
© Reuters.  UPDATE 1-Oil stocks help FTSE 100 outperform amid trade tensions
UK100
-
DE40
-
BATS
-
BP
-
SHEL
-
PFC
-
RKT
-
DGE
-
COB
-
MS
-
OCDO
-
ENT
-
STOXX
-
VM
-
INDV
-
VMUK
-

* FTSE 100 down 0.03 pct

* Consumer staples multinationals hit by trade fears

* Cobham jumps 4.6 pct on MS upgrade

* Indivior gains as U.S. court blocks generic drug

* Energy stocks stage turnaround

(Updates prices, adds details, quotes)

By Helen Reid

LONDON, June 18 (Reuters) - Britain's top stock index dipped on Monday as trade tensions between the United States and China kept the pressure on equity markets across Europe, weighing on multinational companies.

The FTSE 100 .FTSE fell 0.03 percent to its lowest since May 30 but substantially outperformed other European stock markets. Germany's DAX .GDAXI - home to big autos stocks on the trade dispute's front line - sank 1.4 percent while the STOXX 600 fell 0.8 percent.

Strong energy stocks underpinned the FTSE 100, while a weaker pound also boosted the index's mainly exporting companies.

U.S. President Donald Trump announced tariffs on $50 billion of Chinese imports on Friday, laying out a list of more than 800 imports including cars that would be subject to a 25 percent tariff starting on July 6. said it would respond with tariffs "of the same scale and strength" and that any previous trade deals with Trump were "invalid."

Multinational consumer stocks, vulnerable to higher barriers to trade, were the worst performing, with heavyweights Diageo DGE.L , Reckitt Benckiser RB.L and British American Tobacco BATS.L down.

Oil stocks opened lower but jumped into positive territory as crude prices snapped back ahead of Friday's OPEC meeting, expected to result in production increases. was falling earlier after China threatened duties on American oil imports. majors BP BP.L and Royal Dutch Shell RDSa.L turned from the biggest drag to the biggest boost to the index, rising 1.2 to 1.3 percent by the close.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Mid-cap oil services firm Petrofac (LON:PFC) declined 1.3 percent as a negative note from Morgan Stanley (NYSE:MS) weighed.

Analysts at the broker said the market's focus was on whether Petrofac had sufficient liquidity to repay a $677 million October bond in cash or whether additional capital would be required.

Sterling weakened, helping support the FTSE, as traders cut positions in the currency ahead of a Bank of England policy meeting this week and another parliamentary confrontation over the government's Brexit plan. in Ocado OCDO.L fell to their lowest in ten days, down 7.8 percent, on the online grocer's first day of trading on the FTSE 100.

Promotion means index-tracking funds are forced to buy the stock, but Ocado is already up 162 percent this year.

Bookmaker GVC GVC.L rose 2.3 percent on its first day of trading.

In dealmaking news, mid-sized bank CYBG CYBGC.L sealed a deal to acquire Virgin Money VM.L for 1.7 billion pounds, creating Britain's sixth-largest bank by assets. Money shares initially rose more than 2 percent, before reversing course to end the day down 2.2 percent. CYBG shares were down 0.7 percent.

Also among mid-caps, Cobham COB.L shares rose 4.5 percent after Morgan Stanley upgraded the defence stock to "overweight" from "equal-weight". think current management have stabilised performance, with necessary costs sunk and measures taken to aid operational delivery," they wrote.

"With multi-year upcycles beginning in core defence and aerospace markets, and other niche exposures appearing to be at or close to the bottom, we see consensus underpinned."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Shares in drugmaker Indivior INDV.L rose 1.6 percent after a U.S. court granted a temporary restraining order blocking Dr Reddy's Laboratories from launching a generic version of the firm's best-selling opioid addiction treatment. was still far from recovering its losses from Friday when it sank 27 percent on fears of a generic launch.

Overall British stocks have performed well in recent weeks, and analysts have upgraded earnings expectations.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Analysts FTSE earnings

https://reut.rs/2JLxIZS

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.